ReVision Implant secured €4 million in an oversubscribed funding round backed by private investors. The round included existing investors and new backers, including European business leaders and medtech operators. The funding will support clinical development of its brain-computer interface technology for severe blindness, cleanroom infrastructure, in-house manufacturing, team expansion, regulatory compliance, product development, and operational scale-up. The company also has support from public programmes including the €2.4 million FlairVision project and is supported by Plug and Play and imec.istart incubators.
About ReVision Implant
A Belgian neurotechnology company developing a cortical visual prosthesis and brain-computer interface technology designed to help restore functional vision in people with severe blindness.
null, Belgium
Read Company ProfileFrequently Asked Questions
What type of funding round did ReVision Implant raise?
ReVision Implant raised a unspecified round.
How much did ReVision Implant raise in its unspecified?
ReVision Implant raised $4,000,000 EUR in its unspecified.
When did ReVision Implant raise its unspecified?
ReVision Implant raised its unspecified on 2026-05-26.
What type of investment was ReVision Implant's unspecified?
ReVision Implant's unspecified was a equity investment.
How will ReVision Implant use the funds from its unspecified?
ReVision Implant plans to use the funds for: advance clinical development, build cleanroom infrastructure, bring manufacturing steps in-house, expand team, advance regulatory compliance, advance clinical programme, continue product development, strengthen collaborations with other medtech companies, operational scale-up.